Unipolar Depression
82
10
10
53
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Research Maturity
53 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.3%
6 terminated out of 82 trials
89.8%
+3.3% vs benchmark
21%
17 trials in Phase 3/4
19%
10 of 53 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 53 completed trials
Clinical Trials (82)
Effect of Tao Calligraphy Meditation and Energized Water on Depression
RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)
Effectiveness of Light Therapy Across Seasons
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression
Bright Light Therapy for Depressed Geriatric Inpatients
Cognitive Enhancement in Unipolar Depression With Yoga
Enoxolone in Major Depression - Biomarker-outcome Relationship
Transcranial Direct Current Stimulation for Depression
Validation of EmoDTx as a Digital Endpoint for Mood Monitoring in Adult Patients Suffering From Unipolar Depression
Mechanism of Action of Electroconvulsive Therapy
Title: Safety and Feasibility of Individualized Low Amplitude Seizure Therapy (iLAST)
Ketamine As an Adjunctive Therapy for Major Depression (2)
RTMS Feasibility Study on Adolescent Depression Stimulation
Efficacy of Convulsive Therapies During Continuation
Voice Changes During ECT
Mood Disorders in Multiple Sclerosis Patients
Effect of Intermittent and Continuous Theta Burst Stimulation on Sleep, Daytime Sleepiness, and Fatigue in Depression
Multisite rTMS for Mood, Cognitive Impairment and Other Symptoms of Depression
Neurofeedback as a Treatment Tool for Depression